Lairson D R, Swint J M
Health Policy. 1988;9(3):309-15. doi: 10.1016/0168-8510(88)90019-x.
This paper describes economic issues pertinent to health care technology assessment. Of interest are the allocation of resources between health and other sectors of the economy, between alternative services within the health sectors, and the costs of producing the services that are selected. These issues are discussed and then illustrated by reference to a specific area of health care technology: screening for and intervention against genetic diseases. It is concluded that investments in screening programs for Tay Sachs disease and Down Syndrome are allocatively efficient. Indications are that such investments are also efficient for interventions against Neural Tube Defects; however, there are complex ethical issues involved. There are many genetic diseases for which screening tests have yet to be developed. As such tests become available, each will have to be evaluated on its own merits relative to alternative health sector investments.
本文描述了与医疗技术评估相关的经济问题。值得关注的是经济中卫生部门与其他部门之间的资源分配、卫生部门内不同服务之间的资源分配，以及所选服务的生产成本。将对这些问题进行讨论，然后通过参考医疗技术的一个特定领域进行说明：遗传性疾病的筛查和干预。得出的结论是，对泰-萨克斯病和唐氏综合征筛查项目的投资在配置上是有效的。有迹象表明，此类投资对于预防神经管缺陷也是有效的；然而，其中涉及复杂的伦理问题。还有许多遗传性疾病尚未开发出筛查测试。随着此类测试的出现，每项测试都必须根据其相对于卫生部门其他投资的自身价值进行评估。
